BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT)

Last Price11.51

Change+0.00 (0.00%)

NASDAQ · Last Trade: Jan 14th, 8:55 AM EST

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?

Via The Motley Fool · December 22, 2025